tirzepatide and zepbound the same FDA Approves (tirzepatide) for Chronic Weight Management-CliniExpert Zepbound (Tirzepatide) for Weight Loss

What to do when a blockbuster drug for one condition disrupts the hormone behind another blockbuster drug: a case of informed consent.

Chicory Root Inulin nourishes beneficial bacteria and cuts bloating

Semaglutide can lower blood pressure through weight loss and direct cardiovascular effects, but individual responses vary significantly

For research use, reconstitute the lyophilised powder with sterile bacteriostatic water (available separately)

Study: TripleHormone Receptor Agonist Retatrutide for Obesity (Phase 2 Trial, NEJM) Drug: Retatrutide a triple agonist (GLP-1, GIP, and glucagon receptors) Key Findings: Up to 28.7% mean weight loss at higher doses Marked improvements in insulin sensitivity and cardiometabolic risk factors Weight loss approaching outcomes seen with bariatric surgery, without surgery What makes Retatrutide unique is its triple-hormone mechanism, simultaneously targeting appetite regulation, energy expenditure, and glucose metabolism

Learn simple strategies to boost results, from adjusting your dose to diet and exercise tweaks.